Eva Roman
Overview
Explore the profile of Eva Roman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
615
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Diaz-Ruiz R, Poca M, Roman E, Panadero-Gomez R, Cuyas B, Banares I, et al.
Nutrients
. 2025 Jan;
17(2.
PMID: 39861356
Decompensated cirrhosis is characterized by systemic inflammation and innate and adaptive immune dysfunction. Hepatic encephalopathy (HE) is a prevalent and debilitating condition characterized by cognitive disturbances in which ammonia and...
2.
Laghi L, Ortiz M, Rossi G, Roman E, Mengucci C, Canto E, et al.
Biomolecules
. 2024 Nov;
14(11).
PMID: 39595586
Frailty in cirrhosis or advanced chronic liver disease (ACLD) is a relevant prognostic factor. In the present study, we aimed to analyze potential biomarkers associated with frailty and its improvement...
3.
Abril A, Alejandre J, Mariscal A, Alserawan L, Rabella N, Roman E, et al.
Sci Rep
. 2024 Jul;
14(1):15918.
PMID: 38987550
No abstract available.
4.
Abril A, Alejandre J, Mariscal A, Alserawan L, Rabella N, Roman E, et al.
Sci Rep
. 2024 Jun;
14(1):12725.
PMID: 38830902
Humoral immunity in COVID-19 includes antibodies (Abs) targeting spike (S) and nucleocapsid (N) SARS-CoV-2 proteins. Antibody levels are known to correlate with disease severity, but titers are poorly reported in...
5.
Roman E, Kaur N, Sanchez E, Poca M, Padros J, Nadal M, et al.
Hepatol Commun
. 2024 May;
8(5).
PMID: 38701490
Background: Frailty is a predictive factor of hospitalization, falls, and mortality in patients with cirrhosis, regardless of the degree of liver failure. The aim was to analyze whether a multifactorial...
6.
Cuyas B, Huerta A, Poca M, Alvarado-Tapias E, Brujats A, Roman E, et al.
Sci Rep
. 2024 Feb;
14(1):2718.
PMID: 38302563
Infections are a major cause of morbidity and mortality in cirrhosis, especially those caused by multi-drug resistant bacteria. During the COVID-19 pandemic, the incidence and type of infection in these...
7.
Mehta G, Riva A, Ballester M, Uson E, Pujadas M, Carvalho-Gomes A, et al.
Hepatol Commun
. 2023 Oct;
7(11).
PMID: 37870985
Background: Vaccine hesitancy and lack of access remain major issues in disseminating COVID-19 vaccination to liver patients globally. Factors predicting poor response to vaccination and risk of breakthrough infection are...
8.
Laghi L, Roman E, Lan Q, Nieto J, Canalda-Baltrons A, Poca M, et al.
Hepatol Commun
. 2023 Apr;
7(4).
PMID: 37026745
To explore the potential mechanisms underlying the effects of a probiotic in cirrhotic patients, we analyzed the blood metabolome using proton nuclear magnetic resonance (1H-NMR) spectroscopy in 32 patients with...
9.
Roman E, Poca M, Amoros-Figueras G, Rosell-Ferrer J, Gely C, Nieto J, et al.
Sci Rep
. 2021 Oct;
11(1):20415.
PMID: 34650096
The phase angle is a versatile measurement to assess body composition, frailty and prognosis in patients with chronic diseases. In cirrhosis, patients often present alterations in body composition that are...
10.
Arroyo-Diaz J, Julve J, Vlacho B, Corcoy R, Ponte P, Roman E, et al.
Front Public Health
. 2021 Oct;
9:758347.
PMID: 34631653
The study aim was to assess the association of vitamin D supplementation before hospital admission and severe outcomes in subjects admitted for COVID-19. We performed a cross-sectional analysis of pseudonymised...